Peter Fromen

Insider

First SEC filing: March 4, 2022 · Latest: March 4, 2022

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

4 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
March 2, 2022	PACB	A	50,000	—	—	190,280 Direct	+35.64%	Acquired	(price as of 2026-08-19)
March 2, 2022	PACB	A	298,700	—	—	298,700 Direct	—	Acquired	(price as of 2026-08-19)
Jan. 11, 2022	PACB	S	19,720	$14.30	$281,996	140,280 Direct	-12.32%	Disposed	-91.4% (price as of 2026-08-19)
Jan. 8, 2021	PACB	A	160,000	—	—	160,000 Direct	—	Acquired	(price as of 2026-08-19)
Jan. 8, 2021	PACB	A	320,000	—	—	320,000 Direct	—	Acquired	(price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
March 2, 2022	PACB	Stock Option (right to buy)	Common Stock (298,700)	$11.70	March 2, 2032	298,700	Acquired
Jan. 8, 2021	PACB	Stock Option (right to buy)	Common Stock (320,000)	$36.70	Jan. 8, 2031	320,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Chief Commercial Officer

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2022	—	—	—	—	—	—	—	—

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.